Angelo Civitella
Papers
12
Total Citations
185
H-Index
7
About
Angelo Civitella has emerged as a leading voice in robotic and minimally invasive urological surgery, with research concentrated on the clinical validation and optimization of next-generation robotic platforms — most notably the Hugo™ RAS System by Medtronic. His work addresses a critical gap in the field: while robotic surgery has transformed urology since the early 2000s, newer platforms require rigorous independent evaluation before widespread adoption. Civitella has systematically tackled this challenge, producing foundational studies on feasibility, safety, trocar placement, docking configurations, and perioperative outcomes for procedures including robot-assisted partial nephrectomy (RAPN) and radical prostatectomy using the Hugo™ system. His most cited contribution, a 2023 state-of-the-art review accumulating 56 citations, has become an important reference for surgeons navigating an increasingly competitive robotic landscape. Beyond technical description, Civitella has advanced the field conceptually — developing a novel proficiency scoring system to assess surgical skill transfer from laparoscopy to robotics, and introducing the "Delta neobladder," a simplified intracorporeal technique for bladder reconstruction. With over 180 cumulative citations across recent publications and growing multicenter collaborations, his research is actively shaping how the surgical community integrates and evaluates emerging robotic technologies in urological oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10